Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kyle Wathen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Trials (London, England)|October 7, 2017
A simulation study of outcome adaptive randomization in multi-arm clinical trialsJ Kyle Wathen, Peter F Thall
Statistics in Medicine|April 5, 2005
Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatmentsPeter F Thall, J Kyle Wathen
Statistics in Medicine|August 30, 2008
Bayesian adaptive model selection for optimizing group sequential clinical trialsJ Kyle Wathen, Peter F Thall
Current Opinion in Oncology|June 6, 2008
Bayesian designs to account for patient heterogeneity in phase II clinical trialsPeter F Thall, J Kyle Wathen
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Practical Bayesian adaptive randomisation in clinical trialsPeter F Thall, J Kyle Wathen
Clinical Trials (London, England)|March 4, 2009
Bayesian model averaging in meta-analysis: vitamin E supplementation and mortalityDonald Berry, J Kyle Wathen, Margaret Newell
Contemporary Clinical Trials Communications|March 23, 2023
A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI)J Kyle Wathen, Shyla Jagannatha, Seth Ness, et al.
Statistics in Medicine|October 24, 2007
Accounting for patient heterogeneity in phase II clinical trialsJ Kyle Wathen, Peter F Thall, John D Cook, et al.
Statistics in Medicine|July 19, 2005
Continuous Bayesian adaptive randomization based on event times with covariatesYing Kuen Cheung, Lurdes Y T Inoue, J Kyle Wathen, et al.
Leukemia|October 18, 2012
A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patientsE J Freireich, B Lichtiger, G Mattiuzzi, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Trials (London, England)|October 7, 2017
A simulation study of outcome adaptive randomization in multi-arm clinical trialsJ Kyle Wathen, Peter F Thall
Statistics in Medicine|April 5, 2005
Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatmentsPeter F Thall, J Kyle Wathen
Statistics in Medicine|August 30, 2008
Bayesian adaptive model selection for optimizing group sequential clinical trialsJ Kyle Wathen, Peter F Thall
Current Opinion in Oncology|June 6, 2008
Bayesian designs to account for patient heterogeneity in phase II clinical trialsPeter F Thall, J Kyle Wathen
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Practical Bayesian adaptive randomisation in clinical trialsPeter F Thall, J Kyle Wathen
Clinical Trials (London, England)|March 4, 2009
Bayesian model averaging in meta-analysis: vitamin E supplementation and mortalityDonald Berry, J Kyle Wathen, Margaret Newell
Contemporary Clinical Trials Communications|March 23, 2023
A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI)J Kyle Wathen, Shyla Jagannatha, Seth Ness, et al.
Statistics in Medicine|October 24, 2007
Accounting for patient heterogeneity in phase II clinical trialsJ Kyle Wathen, Peter F Thall, John D Cook, et al.
Statistics in Medicine|July 19, 2005
Continuous Bayesian adaptive randomization based on event times with covariatesYing Kuen Cheung, Lurdes Y T Inoue, J Kyle Wathen, et al.
Leukemia|October 18, 2012
A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patientsE J Freireich, B Lichtiger, G Mattiuzzi, et al.
Pageof 2